Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -0.71% | -12.70% | +14.29% |
Apr. 01 | HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 01 | HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 52.95M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.46
x | P/E ratio 2025 * |
-2.55
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.07% |
1 day | -0.71% | ||
1 week | -12.70% | ||
1 month | -20.00% | ||
3 months | +21.74% | ||
6 months | -16.67% | ||
Current year | +14.29% |
Managers | Title | Age | Since |
---|---|---|---|
Hing Wong
FOU | Founder | 70 | 18-04-01 |
Rebecca Byam
DFI | Director of Finance/CFO | 68 | 19-09-30 |
Peter Rhode
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Garrett
CHM | Chairman | 73 | 21-04-30 |
Hing Wong
FOU | Founder | 70 | 18-04-01 |
Rick Greene
BRD | Director/Board Member | 59 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 1.4 | -0.71% | 12,997 |
24-04-29 | 1.41 | +0.72% | 2,213 |
24-04-26 | 1.4 | -4.12% | 2,444 |
24-04-25 | 1.46 | -2.67% | 2,755 |
24-04-24 | 1.5 | -6.46% | 888 |
Delayed Quote Nasdaq, April 30, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 53.33M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- HCWB Stock